These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38389896)

  • 21. Metabolism and functions of copper in brain.
    Scheiber IF; Mercer JF; Dringen R
    Prog Neurobiol; 2014 May; 116():33-57. PubMed ID: 24440710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiocopper for the imaging of copper metabolism.
    Hueting R
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):231-8. PubMed ID: 24634197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homeodomain-interacting protein kinase maintains neuronal homeostasis during normal
    Lazaro-Pena MI; Cornwell AB; Diaz-Balzac CA; Das R; Ward ZC; Macoretta N; Thakar J; Samuelson AV
    Elife; 2023 Jun; 12():. PubMed ID: 37338980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
    Squitti R; Ventriglia M; Gennarelli M; Colabufo NA; El Idrissi IG; Bucossi S; Mariani S; Rongioletti M; Zanetti O; Congiu C; Rossini PM; Bonvicini C
    Mol Neurobiol; 2017 Jan; 54(1):671-681. PubMed ID: 26758278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
    Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
    J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
    Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
    Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.
    Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F
    Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.
    Squitti R; Siotto M; Arciello M; Rossi L
    Metallomics; 2016 Sep; 8(9):863-73. PubMed ID: 27499330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadmium alters whole animal ionome and promotes the re-distribution of iron in intestinal cells of
    Sharma AK; Finney L; Vogt S; Vatamaniuk OK; Kim S
    Front Physiol; 2023; 14():1258540. PubMed ID: 37822680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing effects of excess copper levels in a human astrocytic cell line with focus on oxidative stress markers.
    Witt B; Stiboller M; Raschke S; Friese S; Ebert F; Schwerdtle T
    J Trace Elem Med Biol; 2021 May; 65():126711. PubMed ID: 33486291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
    Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidylglycine α-amidating monooxygenase heterozygosity alters brain copper handling with region specificity.
    Gaier ED; Miller MB; Ralle M; Aryal D; Wetsel WC; Mains RE; Eipper BA
    J Neurochem; 2013 Dec; 127(5):605-19. PubMed ID: 24032518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular mechanisms underlying copper homeostasis in Mammalian cells].
    Ogra Y
    Nihon Eiseigaku Zasshi; 2014; 69(2):136-45. PubMed ID: 24858509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson Disease.
    Barber RG; Grenier ZA; Burkhead JL
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33804693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
    Wang B; Wang XP
    Curr Neuropharmacol; 2019; 17(6):539-549. PubMed ID: 29737252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHCA-1 is a copper-regulated CTR1 homolog required for normal development, copper accumulation, and copper-sensing behavior in
    Yuan S; Sharma AK; Richart A; Lee J; Kim BE
    J Biol Chem; 2018 Jul; 293(28):10911-10925. PubMed ID: 29784876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strength of Cu-efflux response in Escherichia coli coordinates metal resistance in Caenorhabditis elegans and contributes to the severity of environmental toxicity.
    Shafer CM; Tseng A; Allard P; McEvoy MM
    J Biol Chem; 2021 Sep; 297(3):101060. PubMed ID: 34375643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism.
    Chung CY; Posimo JM; Lee S; Tsang T; Davis JM; Brady DC; Chang CJ
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18285-18294. PubMed ID: 31451653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.